EyePoint Pharmaceuticals
EYPT
EYPT
41 hedge funds and large institutions have $20.6M invested in EyePoint Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $32.2M → $20.6M (-$11.7M)
Holders
41
Holding in Top 10
–
Calls
$2.48M
Puts
$709K
Top Buyers
| 1 | +$553K | |
| 2 | +$486K | |
| 3 | +$442K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$429K |
| 5 |
Two Sigma Investments
New York
|
+$299K |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$1.65M | |
| 3 | -$852K | |
| 4 |
Jane Street
New York
|
-$540K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$382K |